Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Complexa initiates phase I trial of kidney injury candidate

May 5, 2014

GlaxoSmithKline obtains FDA priority review designation for Promacta/Revolade

May 5, 2014

Ono and Nissan Chemical discontinue license agreement

May 2, 2014

Sotatercept obtains FDA orphan drug designation

May 2, 2014

Boehringer Ingelheim's antithrombotic receives positive opinion from the EMA

April 28, 2014

Biogen Idec licenses Amunix's Factor VIII product

April 23, 2014

Phase III trial of Baxter's BAX-111 achieves primary endpoint

April 17, 2014

Akebia Therapeutics completes enrollment in a phase IIb study of AKB-6548

April 16, 2014

Biogen Idec and Sobi report topline results from phase III Eloctate trial

April 11, 2014

U.S. researchers patent new lentiviral vectors for stem cell gene therapy

April 9, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 27, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 27, 2025
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...
OS Therapies heading to FDA with positive osteosarcoma data
BioWorld
With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies Inc. anticipates a regulatory filing...
Vilastobart set apart? Xilio phase II combo performs in CRC
BioWorld
“The [colorectal cancer field is moving, and thankfully it’s moving quickly,” said Marwan Fakih, gastrointestinal specialist at City of Hope, speaking about...